BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 16144692)

  • 1. Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.
    Axelson H; Fredlund E; Ovenberger M; Landberg G; Påhlman S
    Semin Cell Dev Biol; 2005; 16(4-5):554-63. PubMed ID: 16144692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models.
    Holmquist L; Löfstedt T; Påhlman S
    Adv Exp Med Biol; 2006; 587():179-93. PubMed ID: 17163166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced dedifferentiation in neuroblastoma cells.
    Jögi A; Øra I; Nilsson H; Poellinger L; Axelson H; Påhlman S
    Cancer Lett; 2003 Jul; 197(1-2):145-50. PubMed ID: 12880974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia.
    Nilsson H; Jögi A; Beckman S; Harris AL; Poellinger L; Påhlman S
    Exp Cell Res; 2005 Feb; 303(2):447-56. PubMed ID: 15652356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype.
    Jögi A; Øra I; Nilsson H; Lindeheim A; Makino Y; Poellinger L; Axelson H; Påhlman S
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7021-6. PubMed ID: 12011461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells.
    Holmquist L; Jögi A; Påhlman S
    Int J Cancer; 2005 Aug; 116(2):218-25. PubMed ID: 15800931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia, pseudohypoxia and cellular differentiation.
    Mohlin S; Wigerup C; Jögi A; Påhlman S
    Exp Cell Res; 2017 Jul; 356(2):192-196. PubMed ID: 28284840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior.
    Jögi A; Vallon-Christersson J; Holmquist L; Axelson H; Borg A; Påhlman S
    Exp Cell Res; 2004 May; 295(2):469-87. PubMed ID: 15093745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation.
    Edsjö A; Holmquist L; Påhlman S
    Semin Cancer Biol; 2007 Jun; 17(3):248-56. PubMed ID: 16828305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotype.
    Hedborg F; Fischer-Colbrie R; Ostlin N; Sandstedt B; Tran MG; Maxwell PH
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.
    Holmquist-Mengelbier L; Fredlund E; Löfstedt T; Noguera R; Navarro S; Nilsson H; Pietras A; Vallon-Christersson J; Borg A; Gradin K; Poellinger L; Påhlman S
    Cancer Cell; 2006 Nov; 10(5):413-23. PubMed ID: 17097563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
    Helczynska K; Kronblad A; Jögi A; Nilsson E; Beckman S; Landberg G; Påhlman S
    Cancer Res; 2003 Apr; 63(7):1441-4. PubMed ID: 12670886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
    Applebaum MA; Jha AR; Kao C; Hernandez KM; DeWane G; Salwen HR; Chlenski A; Dobratic M; Mariani CJ; Godley LA; Prabhakar N; White K; Stranger BE; Cohn SL
    Oncotarget; 2016 Nov; 7(47):76816-76826. PubMed ID: 27765905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIF-2α-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization.
    Pietras A; Johnsson AS; Påhlman S
    Curr Top Microbiol Immunol; 2010; 345():1-20. PubMed ID: 20517717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvesicles as mediators of intercellular communication in cancer.
    Antonyak MA; Cerione RA
    Methods Mol Biol; 2014; 1165():147-73. PubMed ID: 24839024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells.
    Bhaskara VK; Mohanam I; Rao JS; Mohanam S
    PLoS One; 2012; 7(2):e30905. PubMed ID: 22363512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells.
    Löfstedt T; Fredlund E; Noguera R; Navarro S; Holmquist-Mengelbier L; Beckman S; Påhlman S; Axelson H
    Exp Cell Res; 2009 Jul; 315(11):1924-36. PubMed ID: 19254710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial neural network classifier predicts neuroblastoma patients' outcome.
    Cangelosi D; Pelassa S; Morini M; Conte M; Bosco MC; Eva A; Sementa AR; Varesio L
    BMC Bioinformatics; 2016 Nov; 17(Suppl 12):347. PubMed ID: 28185577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site.
    Rössler J; Stolze I; Frede S; Freitag P; Schweigerer L; Havers W; Fandrey J
    J Cell Biochem; 2004 Sep; 93(1):153-61. PubMed ID: 15352172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.
    Hsu DM; Agarwal S; Benham A; Coarfa C; Trahan DN; Chen Z; Stowers PN; Courtney AN; Lakoma A; Barbieri E; Metelitsa LS; Gunaratne P; Kim ES; Shohet JM
    Cancer Res; 2013 Jul; 73(13):4134-46. PubMed ID: 23687340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.